Test Price
2,500 AED✅ Home Collection Available
Chromosomal SNP Microarray for Products of Conception (POC) Testing in UAE | 2500 AED
Executive Summary & Core Metrics
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✓Specimen Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- ✓Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by DHA-licensed professionals.
- ✓Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This state‑of‑the‑art chromosomal microarray (CMA) with SNP probes analyses all 24 chromosomes in products of conception (POC) to unmask copy‑number variants, uniparental disomy, and pathogenic microdeletions down to 25 kb resolution. It is the first‑line genetic test for miscarriage tissue, providing critical answers for couples with recurrent pregnancy loss. The assay employs the Affymetrix CytoScan Optima Suite, combining high‑density SNP coverage with whole‑genome copy‑number analysis, ensuring detection of triploidy, UPD, and mosaicism without requiring viable cultured cells.
| Feature | This Test (CMA OPTIMA) | Closest Alternative (Standard Karyotype) |
|---|---|---|
| Precision / Resolution | SNP‑based CMA ≥25 kb; detects UPD & triploidy | ~5‑10 Mb; misses submicroscopic CNVs |
| Method | Affymetrix CytoScan Optima Suite (CMA+SNP) | G‑banded chromosome analysis |
| Turn‑around Time | 10 working days | 14‑21 calendar days |
| Culture Failure Rate | <5% (no requirement for live cells) | 10‑20% risk of failure |
Physician Insight & Safety Protocols
Note from Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403): The chromosomal SNP microarray on products of conception delivers the highest diagnostic yield for miscarriage investigations, yet results must always be interpreted alongside parental karyotypes and the full clinical history. A normal microarray does not exclude all genetic causes; variants of uncertain significance require cautious evaluation. I recommend discussing findings with your obstetrician or genetic counsellor before making any clinical decisions.
Important Advisory – Medication Continuity
⚠ Do not discontinue prescribed medication without consulting your doctor. This test result alone should not prompt any change to your ongoing treatment plan.
Exclusion Criteria & Emergency Red Flags
- Exclusion criteria for POC collection: Inadequate tissue amount (<2 mg), specimen submitted in formalin or fixative, missing Genomic Microarray Requisition Form (Form 19).
- Post‑procedure red flags – proceed to emergency immediately if you experience: severe lower abdominal pain, heavy vaginal bleeding (soaking >1 pad per hour), fever >38°C, foul‑smelling discharge, or signs of shock (dizziness, fainting).
- Incompatible samples: Samples stored at incorrect temperature, or those that have been exposed to extreme heat, must be recollected.
Patient FAQ & Clinical Guidance
1. What does the Chromosomal SNP Microarray for POC test detect?
It identifies chromosomal imbalances—deletions, duplications, uniparental disomy, and triploidy—in miscarriage tissue that may have caused the pregnancy loss. The high‑resolution SNP platform can detect abnormalities as small as 25 kb, far beyond the resolution of a standard karyotype.
2. How should I prepare and what sample is needed?
Provide 5 mg (minimum 2 mg) of products of conception tissue collected in sterile normal saline; you must also complete the mandatory Genomic Microarray Requisition Form 19. The specimen is obtained during a hospital‑based procedure and transported under controlled conditions to our ISO‑certified laboratory.
3. What is the cost and turnaround time for this test in the UAE?
The test is priced at 2500 AED, with results delivered within 10 working days after sample receipt at DNA Labs UAE. Reports are issued electronically and include a telephonic consultation with a DHA‑licensed genetic specialist to explain the findings.
4. Who performs the analysis and how are results validated?
The assay is performed at DNA Labs UAE under the supervision of Consultant Medical Genetics Lina Osama Zaki Quteineh (DHA: 9294403). Every result undergoes dual verification by a senior molecular geneticist and a clinical geneticist before release.
UAE Regulatory & Data Privacy Adherence
Compliance Framework: This test and all associated data handling procedures comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety follow Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory is accredited under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) and holds DHA Facility License No. 1143.
All genetic data are encrypted, stored in‑country, and accessible only to the requesting physician and the patient. Results are never shared with third parties without explicit written consent.
Clinical & Logistical Metadata
| Test Name | Chromosomal SNP Microarray for Products of Conception (POC) |
| Price (AED) | 2500 AED |
| Turnaround Time | 10 working days |
| Sample Type / Matrix | Products of Conception (POC) Tissue – Hospital Extraction Only |
| Methodology Used | Affymetrix CytoScan Optima Suite (CMA+SNP) |
| ICD-10-CM Code | O36.80 |
| LOINC Code | 82125-4 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 · Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE · DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians